|
|
|
40
|
2593DR
|
FAMOTIDINE 20MG TAB (APL/AHI)
|
FAMOTIDINE
|
FAMOTIDINE
|
100'S
|
C
|
24.85
|
0.25
|
TABLET
|
0
|
TAB
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
562812
|
HISTAMINE RECEPTOR ANTAGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
GASTROINTESTINAL DRUGS
|
|
|
|
|
40
|
28439
|
METFORMIN 1G TAB (APL/AHI)
|
METFORMIN
|
METFORMIN
|
100'S
|
A
|
10.76
|
0.11
|
TABLET
|
90
|
TAB
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
682004
|
BIGUANIDES
|
2022-04-01
|
2024-03-31
|
Amend Protocol Quantity
|
Oral
|
6
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
2022-08-15
|
|
|
|
41
|
65712
|
CLOZAPINE 25MG TAB (APL/AHI)
|
CLOZAPINE
|
CLOZAPINE
|
100'S
|
BP
|
122.9498
|
1.2295
|
TAB
|
270
|
TAB
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
|
|
|
ORAL
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
65712
|
CLOZAPINE 25MG TAB (APL/AHI)
|
CLOZAPINE
|
CLOZAPINE
|
100'S
|
BP
|
97.32
|
0.97
|
TABLET
|
270
|
TAB
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2022-07-30
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-03-29
|
|
|
|
40
|
A321AH
|
VENLAFAXINE ER 37.5MG TAB (APL/AHI) VENLAFAXI
|
VENLAFAXINE
|
VENLAFAXINE ER
|
30'S
|
BP
|
10.90
|
0.36
|
TABLET
|
0
|
TAB
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A322HL
|
FLUOXETINE 20MG CAP (APL/AHI)
|
FLUOXETINE
|
FLUOXETINE
|
100'S
|
A
|
11.20
|
0.11
|
CAPSULE
|
120
|
CAP
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A322JV
|
VENLAFAXINE SR 75MG CAP (APL/AHI) VENLAFAXINE
|
VENLAFAXINE
|
VENLAFAXINE SR
|
1000'S
|
BP
|
516.21
|
0.52
|
CAPSULE
|
0
|
CAP
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-03-29
|
|
|
|
40
|
A322KN
|
FLUOXETINE 20MG TAB (APL/AHI)
|
FLUOXETINE
|
FLUOXETINE
|
1000'S
|
A
|
120.97
|
0.12
|
TABLET
|
120
|
CAP
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160420
|
SELECTIVE SEROTONIN REUPTAKE INHIBITORS
|
2022-09-20
|
2024-03-31
|
Package Size Change
|
oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-09-20
|
|
|
|
40
|
A322KR
|
VENLAFAXINE ER 150MG CAP (APL/AHI) VENLAFAXIN
|
VENLAFAXINE
|
VENLAFAXINE ER
|
90'S
|
BP
|
69.43
|
0.77
|
CAPSULE
|
0
|
CAP
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A322KS
|
VENLAFAXINE ER 75MG CAP (APL/AHI) VENLAFAXINE
|
VENLAFAXINE
|
VENLAFAXINE ER
|
30'S
|
BP
|
18.97
|
0.63
|
CAPSULE
|
0
|
CAP
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160416
|
SELECTIVE SEROTONIN/NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
A573P
|
ALENDRONATE 70MG TAB (APL/AHI)
|
ALENDRONATE
|
ALENDRONATE
|
4'S
|
B
|
3.62
|
0.91
|
TABLET
|
0
|
TAB
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
40
|
B051B
|
DOLUTEGRAVIR 50MG TAB (APL/ATB)
|
DOLUTEGRAVIR
|
DOLUTEGRAVIR
|
30'S
|
BL
|
10.66
|
0.36
|
TABLET
|
0
|
TAB
|
APL
|
AUROBINDO PHARMA LTD.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08180812
|
INTEGRASE INHIBITORS
|
2022-04-12
|
2024-03-31
|
Add to Contract as Cat B
|
oral
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-04-12
|
